{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-081327","form_type":"8-K","ticker":"OSCR","cik":"0001568651","company_name":"Oscar Health, Inc.","filed_at":"2023-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.635856+00:00","generated_at":"2026-06-17T12:48:09.195473+00:00","sec_items":["5.02","7.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Oscar Health appoints Mark Bertolini CEO; Schlosser moves to President of Technology","bullets":["Mark Bertolini (ex-Aetna CEO) becomes CEO and board member effective April 3, 2023; Mario Schlosser transitions to President of Technology.","Bertolini receives sign-on equity of 10.32M shares: 2.87M time-vested RSUs and 7.45M performance-vested PSUs with price targets of $11, $16, $39.","Founders Schlosser and Kushner cancel their PSU awards (total 6.34M shares), triggering a ~$46M non-cash charge in Q1 2023.","Inducement plan authorized shares increased from 5M to 18.32M to accommodate Bertolini's grants and annual employee awards.","Company reaffirms full-year 2023 guidance as originally issued on February 9, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-081327","json":"https://secwatch.observer/filing/0001193125-23-081327.json","markdown":"https://secwatch.observer/filing/0001193125-23-081327.md","text":"https://secwatch.observer/filing/0001193125-23-081327.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1568651/000119312523081327/0001193125-23-081327-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1568651/000119312523081327/d487122d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T12:48:09.195473+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1eb5465272","claim":"Mark T. Bertolini was appointed as Chief Executive Officer at Oscar Health, Inc..","evidence_excerpt":"Mark T. Bertolini will join the Company as Chief Executive Officer and a member of the Company’s Board of Directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1568651/000119312523081327/0001193125-23-081327-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"586e5ff53d","claim":"Mario Schlosser changed role as President of Technology at Oscar Health, Inc..","evidence_excerpt":"Co-founder Mario Schlosser will move into the role of President of Technology","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1568651/000119312523081327/0001193125-23-081327-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"moved into the role of"},{"label":"Role","value":"President of Technology"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}